BR9911663A - Processo para mitigar efeitos danosos em células normais de um animal de estimação com câncer submetido à terapia de radiação - Google Patents

Processo para mitigar efeitos danosos em células normais de um animal de estimação com câncer submetido à terapia de radiação

Info

Publication number
BR9911663A
BR9911663A BR9911663-4A BR9911663A BR9911663A BR 9911663 A BR9911663 A BR 9911663A BR 9911663 A BR9911663 A BR 9911663A BR 9911663 A BR9911663 A BR 9911663A
Authority
BR
Brazil
Prior art keywords
radiation therapy
normal cells
pet
harmful effects
cancer radiation
Prior art date
Application number
BR9911663-4A
Other languages
English (en)
Inventor
Deborah J Davenport
Kathy L Gross
Gregory K Ogilvie
Michael S Hand
Original Assignee
Colgate Palmolive Co
Univ Colorado State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co, Univ Colorado State Res Found filed Critical Colgate Palmolive Co
Publication of BR9911663A publication Critical patent/BR9911663A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

"PROCESSO PARA MITIGAR EFEITOS DANOSOS EM CéLULAS NORMAIS DE UM ANIMAL DE ESTIMAçãO COM CâNCER SUBMETIDO A TERAPIA DE RADIAçãO". A severidade do dano causado à pele e à mucosa de animais cancerosos submetidos à terapia de radiação é mitigada pela alimentação do animal com uma composição alimentícia nutricionalmente balanceada contendo ácidos graxos ómega-6-poliinsaturados que são suplementados com uma mistura de ácidos graxos ómega-3-poliinsaturados e arginina.
BR9911663-4A 1998-06-29 1999-06-24 Processo para mitigar efeitos danosos em células normais de um animal de estimação com câncer submetido à terapia de radiação BR9911663A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,295 US6015798A (en) 1995-10-10 1998-06-29 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PCT/US1999/014344 WO2000000189A1 (en) 1998-06-29 1999-06-24 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Publications (1)

Publication Number Publication Date
BR9911663A true BR9911663A (pt) 2005-12-20

Family

ID=22310643

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911663-4A BR9911663A (pt) 1998-06-29 1999-06-24 Processo para mitigar efeitos danosos em células normais de um animal de estimação com câncer submetido à terapia de radiação

Country Status (17)

Country Link
US (1) US6015798A (pt)
EP (1) EP1091734B1 (pt)
JP (2) JP4860814B2 (pt)
AR (1) AR019728A1 (pt)
AT (1) ATE249821T1 (pt)
AU (1) AU761266B2 (pt)
BR (1) BR9911663A (pt)
CA (1) CA2336628C (pt)
DE (1) DE69911409T2 (pt)
DK (1) DK1091734T3 (pt)
ES (1) ES2207951T3 (pt)
MX (1) MXPA01000152A (pt)
NO (1) NO329910B1 (pt)
NZ (1) NZ508766A (pt)
TR (1) TR200100457T2 (pt)
WO (1) WO2000000189A1 (pt)
ZA (1) ZA200007650B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa
PE20010524A1 (es) * 1999-09-09 2001-05-23 Nestle Sa Composicion nutricional para animales domesticos que contiene una fuente de nutrientes con propiedades antioxidantes
WO2001082720A1 (en) * 2000-05-01 2001-11-08 The Iams Company Pet food composition for reducing inflammatory response in cats
JP2003534019A (ja) 2000-06-01 2003-11-18 ユナイテッド フィーズ，インコーポレーテッド 動物飼料および方法
ATE492166T1 (de) 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren
US8841344B2 (en) 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US6899904B2 (en) * 2002-11-14 2005-05-31 The Meow Mix Company Pet food compositions having electrostatically charged ingredient
US6841179B2 (en) 2002-11-14 2005-01-11 The Meow Mix Company Pet food compositions comprising electrostatically charged gelatin
US20060204636A1 (en) * 2002-12-23 2006-09-14 Butterwick Richard F Food for gastrointestinal health
GB0311081D0 (en) * 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
DE602004015472D1 (de) * 2003-08-11 2008-09-11 Hills Pet Nutrition Inc Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633246B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
JP2007502805A (ja) * 2003-08-18 2007-02-15 ビーティージー・インターナショナル・リミテッド 神経変性状態の処置
DK2260718T3 (en) 2003-11-25 2014-11-17 Virginia Tech Intell Prop Composition which an animal to be taken, for use in reducing MAP kinase activity
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
GB0425932D0 (en) * 2004-11-25 2004-12-29 Btg Int Ltd Structured phospholipids
ES2579430T3 (es) 2004-12-30 2016-08-11 Hill's Pet Nutrition, Inc. Métodos para aumentar la calidad de vida de un animal en crecimiento
GB0504333D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Treatment of cytokine dysregulation
GB0504362D0 (en) * 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US8729133B2 (en) * 2006-02-28 2014-05-20 Cornell University Method for treating cancer
EP2214481B1 (en) 2007-10-15 2019-05-01 United Animal Health, Inc. Method for increasing performance of offspring
WO2009070589A1 (en) * 2007-11-30 2009-06-04 Jbs United, Inc. Method and composition for treating pulmonary hemorrhage
JP6001184B2 (ja) * 2012-11-15 2016-10-05 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 食餌のミネラル制限を介したヘアボール制御
JP2020507628A (ja) 2017-02-13 2020-03-12 ウィンターミュート バイオメディカル, インク.Wintermute Biomedical, Inc. 抗病原体治療組成物
CN113164420A (zh) 2018-10-01 2021-07-23 温特穆特生物医学公司 治疗组合物
CN114829630A (zh) * 2019-12-19 2022-07-29 希尔氏宠物营养品公司 用于评估和降低患上犬科动物甲状腺功能减退症和其它自身免疫性病状的风险的试剂、试剂盒和方法
WO2021126221A1 (en) 2019-12-19 2021-06-24 Hill's Pet Nutrition, Inc. Compositions comprising a particular ratio of insoluble to soluble fibre for use in the treatment of e.g. anxiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
DE68904874T2 (de) * 1988-10-31 1993-07-15 Sandoz Nutrition Ltd Organische verbindungen.
US5780039A (en) * 1992-04-23 1998-07-14 Novartis Nutrition Ag Orally-ingestible nutrition compositions having improved palatability
CA2147109A1 (en) * 1994-04-18 1995-10-19 Gregory A. Reinhart Pet food product containing omega-6 and omega-3 fatty acids and process for reducing inflammatory skin responses
US5776913A (en) * 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
US6015798A (en) * 1995-10-10 2000-01-18 Colgate Palmolive Company Method for reducing the damaging effects of radiation therapy on animal skin and mucosa

Also Published As

Publication number Publication date
WO2000000189A1 (en) 2000-01-06
NO20006575D0 (no) 2000-12-21
NO20006575L (no) 2001-02-28
US6015798A (en) 2000-01-18
JP2009035533A (ja) 2009-02-19
AU761266B2 (en) 2003-05-29
NO329910B1 (no) 2011-01-24
JP5704791B2 (ja) 2015-04-22
ATE249821T1 (de) 2003-10-15
CA2336628C (en) 2009-03-24
EP1091734B1 (en) 2003-09-17
MXPA01000152A (es) 2002-10-17
AU4716799A (en) 2000-01-17
DE69911409T2 (de) 2004-07-08
ZA200007650B (en) 2002-08-28
JP4860814B2 (ja) 2012-01-25
NZ508766A (en) 2003-05-30
ES2207951T3 (es) 2004-06-01
EP1091734A1 (en) 2001-04-18
AR019728A1 (es) 2002-03-13
DK1091734T3 (da) 2004-01-26
DE69911409D1 (de) 2003-10-23
TR200100457T2 (tr) 2001-08-21
CA2336628A1 (en) 2000-01-06
JP2002519320A (ja) 2002-07-02

Similar Documents

Publication Publication Date Title
BR9911663A (pt) Processo para mitigar efeitos danosos em células normais de um animal de estimação com câncer submetido à terapia de radiação
ES2170269T3 (es) Dieta terapeutica para perros con linfoma.
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
DK0950410T3 (da) Konjugeret linolsyresammensætninger
IE791804L (en) Medicated animal feed
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
ES2037244T3 (es) Uso de un aditivo para piensos y pienso que contiene dicho aditivo.
BR0215040A (pt) suplemento de casca de frutas cìtricas secas para uso em ração para aves comerciais
Baker et al. Effect of a combination of diethylstilbestrol and methyltestosterone, sex and dietary protein level on performance and carcass characteristics of finishing swine
BR0314066A (pt) Composição administrável oralmente para melhoria da qualidade da pele
BR0015551A (pt) Método de expandir a faixa de pastagem e um suplemento alimentìcio de animais para uso na mesma
BR0210421A (pt) Método e aparelho para a personalização de um alimento para animais com múltiplos componentes
US20100183580A1 (en) Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate
Futoryan et al. Retinoids and the skin
BR0312591A (pt) Efeito sinérgico da dieta e da interação com ser humano sobre o comportamento de cães
Calvert et al. Effect of linoleic acid on nutritional muscular dystrophy in the chick
Baumgard et al. The effects of heat stress on nutritional and management decisions
ATE261667T1 (de) Gallensäuren enthaltende zootechnische formulierungen
Wannavijit Use of Longan By-products as Feed Additives for Nile Tilapia (Oreochromis niloticus) Culture Under Biofloc System
Hunchak Irynei Ratych—Doctor of Agricultural Sciences, Associate Member of the National Academy of Agricultural Sciences
Loughmiller et al. Dietary total sulfur amino acid requirement for optimal growth performance and carcass characteristics in finishing gilts
Wahlstrom The Effect of Vitamin D in Rations for Growing Pigs Fed in the Absence of Direct Sunlight
ΔΕΜΕΡΤΖΗΣ POSTHTIS AND VULVITIS IN EXPERIMENTALLY INDUCED ZINC DEFICIENT LAMBS
James et al. Effects of increasing levels of spray-dried blood meal and blood cells on nursery pig performance (2000)
Rooke et al. Effect of maternal fatty acid supply on umbilical cord and piglet tissue composition

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA A CLASSIFICACAO DE A61K 31/195, A61K 31/20, A61K 34/23.

Ipc: A23K 1/16 (2008.01), A23K 1/18 (2008.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 E 10 (VIII) DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/202 (2006.01), A23K 20/142 (2016.0